NextCell Pharma AB Stock Nasdaq Stockholm
Equities
SE0009723125
Biotechnology & Medical Research
Sales 2022 | 6.23M 592K | Sales 2023 | 13.96M 1.33M | Capitalization | 124M 11.76M |
---|---|---|---|---|---|
Net income 2022 | -34M -3.23M | Net income 2023 | -39M -3.71M | EV / Sales 2022 | 19.5 x |
Net cash position 2022 | 97.12M 9.23M | Net cash position 2023 | 50.03M 4.75M | EV / Sales 2023 | 5.28 x |
P/E ratio 2022 |
-6.32
x | P/E ratio 2023 |
-3.11
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 81.06% |
Managers | Title | Age | Since |
---|---|---|---|
Mathias Svahn
CEO | Chief Executive Officer | 48 | 14-03-18 |
Edvard Smith
FOU | Founder | 73 | 14-03-18 |
Patrik Fagerholm
DFI | Director of Finance/CFO | 57 | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 74 | 14-03-18 | |
Edvard Smith
FOU | Founder | 73 | 14-03-18 |
Camilla Sandberg
BRD | Director/Board Member | 57 | 16-12-31 |
1st Jan change | Capi. | |
---|---|---|
+22.10% | 47.07B | |
+46.45% | 42.06B | |
-3.12% | 39.98B | |
+36.10% | 33.02B | |
-6.30% | 27.9B | |
+18.71% | 27.63B | |
+46.15% | 14.37B | |
+44.52% | 13.45B | |
+0.19% | 12.03B |